Tegavivint: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

15

Conditions studied

18

US states with sites

1

Countries

Phase breakdown

Phase 1 2 Phase 2 2

Conditions being studied

Condition	Trials
Colorectal cancer	2
Adenomatous Polyposis Coli (APC) Gene Mutation	1
Catenin Beta-1 (CTNNB1) Gene Mutation	1
Colorectal Cancer (CRC)	1
Colorectal Carcinoma	1
Endometrial Carcinoma	1
Melanoma	1
Metastatic Colorectal Carcinoma (mCRC)	1
Neuroblastoma	1
Ovarian Carcinoma	1
Pancreatic Ductal Adenocarcinoma	1
Pancreatic cancer	1
Recurrent Desmoid Fibromatosis	1
Recurrent Ewing Sarcoma	1
Recurrent Hepatoblastoma	1

Recruiting trials involving Tegavivint

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
NCT07463599 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
NCT04851119 · Phase: Phase 1, Phase 2 · Ages: 12 Months to 30 Years · Sex: All (male and female) · 42 locations

Common questions

How many recruiting trials involve Tegavivint?

2 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.